14.3 C
New York
Tuesday, March 21, 2023

Ambrx Biopharma Inc. (NYSE: AMAM): Is It A Buying Opportunity Again?

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. After-hours trades for Ambrx Biopharma Inc. (AMAM) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.21, or -1.99%, to $10.35. The Ambrx Biopharma Inc. has recorded 4,652 volume in the after hours trading session. Earlier, Yahoo Finance discussed this stock as it revealed Ambrx Raises $78 Million and Completes its ATM Program.

From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio

The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.

Get our free report, "Top 5 AI Stocks to Buy for 2023".


Stocks Info

AMAM belongs to the Healthcare sector of the NYSE while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $10.56 and fluctuated between $11.06 as its day high and $10.21 as its day low. The current market capitalization of Ambrx Biopharma Inc. is $373.30M. A total of 1.35 million shares were traded on the day, compared to an average of 5.30M shares.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for AMAM in the last 3 months, the mean price target is $8.50 with high estimates of $11.00 and low estimates of $6.00. In terms of 52-week highs and lows, AMAM has a high of $13.07 and a low of $0.38.

As of this writing, AMAM has an earnings estimate of $0 per share for the current quarter. EPS was calculated based on a consensus of 0 estimates, with a high estimate of $0 per share and a lower estimate of $0.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 3 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AMAM is Buy with a score of 3.75. A total of 1 analysts rated the stock as Buy while 1 rated it as Overweight while 1 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles